<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref38">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Detalle</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Stohr</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Palomo</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Piedra</surname>
    <given-names>P. A.</given-names>
   </name>
   <name>
    <surname>Gilbert</surname>
    <given-names>B. E.</given-names>
   </name>
   <name>
    <surname>Mas</surname>
    <given-names>V.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2016</year>). 
  <article-title>Generation and characterization of ALX-0171, a potent novel therapeutic nanobody for the treatment of respiratory syncytial virus infection</article-title>. 
  <source>Antimicrob. Agents Chemother.</source>
  <volume>60</volume>, 
  <fpage>6</fpage>â€“
  <lpage>13</lpage>. 
  <pub-id pub-id-type="doi">10.1128/AAC.01802-15</pub-id>
  <pub-id pub-id-type="pmid">26438495</pub-id>
 </mixed-citation>
</ref>
